Invited Speakers

Invited Speakers

Dr Lisa Abbott

Lisa is a doctor and barrister and holds degrees in Medicine, Law and Government & Public Administration from the University of Sydney. She was admitted to the NSW Bar in 2005, practising in professional negligence and disciplinary proceedings prior to commencing her medical studies in 2009. Lisa has maintained a keen interest in the intersection between medicine, law and technology. She is currently a Dermatology Registrar at the Skin & Cancer Foundation Inc in Melbourne and is undertaking a Master of Laws by research on the legal implications of smartphone use in clinical dermatology.

Dr Belinda Campbell

Dr Belinda Campbell is an experienced Senior Radiation Oncologist at Peter MacCallum Cancer Centre. She has clinical expertise in the care of patients requiring radiotherapy for both cutaneous and nodal lymphomas, and is a valued member of the multidisciplinary skin lymphoma team at Peter Mac.

Dr Campbell graduated from medical school at The University of Melbourne in 1999, and completed her specialty training in 2007. From 2006 to 2009, she worked at the BC Cancer Agency in Canada, and returned to Australia in late 2009 to take up her current position at Peter Mac. In 2012, she completed her research thesis and graduated with a Master of Medicine (research) from The University of Melbourne.

Dr Campbell is also a Council Member of the International Lymphoma Radiation Oncology Group (ILROG), Associate Senior Editor of the International Journal of Radiation Oncology, Biology and Physics (Red Journal), Associate Editor of the Journal of Medical Imaging and Radiation Oncology (JMIRO), and Senior Lecturer at The University of Melbourne. 



A/Professor Chris McCormack

Assoc. Prof. McCormack has over 25 years of experience in the field of Dermatology. After graduating from Monash University Medical School in 1986, he worked for two years at The Alfred before embarking on a career in the RAAF. He gained his fellowship from the Australasian College of Dermatology in 1996 and was awarded the prize for obtaining the highest mark in the fellowship exams.

In 1998, Assoc. Prof. McCormack started the dermatology service at Australia’s leading cancer hospital, the Peter MacCallum Cancer Centre (PMCC), and is now their Chief Dermatologist. At the same time, he began running the cutaneous lymphoma service at St Vincent’s hospital in conjunction with the PMCC.  Assoc. Prof. McCormack is now considered Australia’s leading dermatology expert in the field, and has developed the cutaneous lymphoma service into one of the foremost research and clinical units in the world.

Assoc. Prof. McCormack is also an expert in the field of skin cancer, including melanoma and non-melanoma skin cancer, and has extensive experience in inflammatory dermatoses such as eczema and psoriasis. He has written numerous papers in peer-reviewed journals has been involved in multiple research projects in each of these fields.



Dr Benjamin Carew

Dr Benjamin Carew BPhty, MBBS, GradCertClinEd, FRACGP, FACD is a general dermatologist with a special interest in the treatment of acne, eczema, psoriasis, and cutaneous malignancies as well as medical education and Tele-dermatology. He also provides a range of Laser and cosmetic treatments.
Dr Carew initially trained and worked as a General practitioner in Central Qld before completing his training as a Dermatologist. He is a visiting Dermatologist at the Mater Hospital where he supervisors training Dermatologists and junior doctors.
Dr Carew has worked as a Medical Educator at the University of Qld (Rural Clinical school of Medicine) as well as with Qld Rural Medical Education and more recently with the Australian Skin Cancer Academy (ASCA). In his role with ASCA he has been involved in the development of the Practical Dermoscopy course for the Australasian College of Dermatology.
In 2018 Dr Carew was appointed to the position of Co- Program Director of the University of Queensland’s Master of Medicine (Skin Cancer) Program.

Dr Matteo Carlino


Matt Carlino (2)Matteo Carlino is a Medical Oncologist at Westmead and Blacktown Hospitals and Clinical Faculty member of the Melanoma Institute Australia. He undertook his a PhD examining predictors of response and mechanisms of resistance to BRAF and MEK inhibitor treated melanoma.

He currently leads the melanoma clinical trials service at Westmead Hospital and continues to be involved in the translational research program based at the Melanoma Institute Australia and the Westmead Institute for Medical Research. He is an investigator on multiple phase I, II and III clinical trials in melanoma targeted and immunotherapy.  

Dr Alex Chamberlain

Dr Alex Chamberlain graduated as a Fellow of the Australasian College of Dermatologists in 2005 having spent two years of his training in Oxford. He is a Senior Lecturer at Monash University and is visiting specialist at the Alfred Hospital/ Victorian Melanoma Service. He has over 50 peer reviewed publications and major interests include dermoscopy and cutaneous oncology. He is in private practice in Malvern, Victoria.

Professor David Ellis


A/Professor David Ellis has been a national figure in lymphoma diagnosis since the inception of immunophenotyping in the 1980’s and has given over 100 invited presentations to national and interstate meetings of haematologists, anatomical pathologists, medical oncologists, radiation oncologists and cancer organisations. He co-chaired the national ACN/NH&MRC Guidelines for the Diagnosis and Management of Lymphoma in 2005 and coordinated the pathology review for a number of Australian Leukaemia Lymphoma Group (ALLG) clinical trials as pathology convenor from 1986 to 2008.

He is past President of the International Academy of Pathology, Australasia and has recently led the introduction of structured pathology reporting of cancer, initially as inaugural chair of the RCPA/Cancer Institute NSW – National Structured Pathology Reporting Project, and subsequently internationally as cofounder and president of the International Collaboration on Cancer Reporting (ICCR) .

Professor Peter Foley

More information will be available soon. 

Dr Lucy Fox

 Dr Lucy Fox (BSci/BCom, MBBS, FRACP, FRCPA) completed combined haematology clinical and pathology training in 2017. She works as a Clinical Haematologist at the Epworth Hospital (Melbourne) and is also a Molecular Haematology Fellow at the Peter MacCallum Cancer Centre. She is enrolled in a Doctorate of Medical Science through the University of Melbourne and her research is on Bone Marrow Failure Syndromes, with a focus on the genetics of these diseases. Her research is supported by both the Melbourne Genomics Health Alliance and Maddie Riewoldt’s Vision.

Professor Gerald Fogarty MBBS, FRANZCR, PhD

Gerald FogartyProfessor Gerald Fogarty MBBS, FRANZCR, PhD is the Director of Radiation Oncology at St Vincent’s Hospital, Sydney. He trained at the Peter MacCallum Cancer Centre, Australia’s largest cancer centre. Prof Fogarty has a PhD and over 80 publications, 30 being first author. He is a senior radiation oncologist with Melanoma Institute of Australia, the largest melanoma centre in the world. He is a board member of the Australian and New Zealand Melanoma Trials Group, one of Australia’s most successful trials groups.    He is the chief investigator of an International Phase III Trial investigating the radiotherapy of melanoma brain metastases, often a terminal event in melanoma, with over $2 million in Cancer Australia funding  His career goal is to establish level one evidence for the treatment of skin cancer with radiotherapy. He also is currently the Master of Warrane College, an affiliated residential College at UNSW.


Dr Robert Gotkin

Robert H. Gotkin, MD, FACS, is a board-certified plastic surgeon who specializes in both aesthetic and reconstructive surgery.  He is Director of Plastic Surgery at Cosmetique Dermatology, Laser and Plastic Surgery, LLP, with offices on Park Avenue in Manhattan and on Long Island’s Gold Coast
In addition to being certified by the American Board of Plastic Surgery, Dr. Gotkin is a Fellow of the American College of Surgeons and an active member in many national and international plastic surgery societies.  He also serves on the Medical Council of the Skin Cancer Foundation – a co-sponsor of this World Congress on Cancers of the Skin.
Named a “Top Doctor” in New York every year since 1998 in the Guide to the Best Doctors in New York, Dr. Gotkin is the author of numerous scientific publications on anatomy, plastic surgery, lasers and cosmetic procedures.  Along with his wife, Dr. Deborah Sarnoff, Dr. Gotkin was a recipient of the CancerCare Humanitarian Award in 2006.  He has volunteered on reconstructive operating expeditions in such countries as Haiti, the Dominican Republic and Peru, yet he is sought out by A-list celebrities and Academy Award winning actors from across the country and around the world. 

Professor Alex Guminski

More information will be available soon. 

Dr Victoria Harris

Dr Victoria Harris graduated with honours in Law from the University of Technology Sydney in 2009. She completed a research thesis during her legal studies on the “status of the human embryo.” Victoria went on to complete a medical degree and following two years of dermatology research at Royal North Shore Hospital and completing a Masters in Philosophy (Medicine) was been accepted into the Australian College of Dermatologist as a registrar. 

Professor John Hawk

Professor John HawkJohn Hawk BSc MD FRCP FRACP Hon FACD is Emeritus Professor and recent Head for twenty-five years of the Photobiology Department, St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals and King’s College, London, having qualified in medicine at Otago University, Dunedin, New Zealand, then worked in general practice in Sydney, Australia, before training in dermatology at St Mary’s and Guy’s Hospitals, and the St John’s Institute of Dermatology, London, and at Harvard Medical School, Boston, USA. He has written hundreds of scientific papers, book chapters and books, was formerly editor of the journal, Clinical and Experimental Dermatology, and lectures extensively by invitation worldwide. He importantly initiated the campaign in England counselling care in the sun and with sunbeds in the 1980s and frequently appeared then and still does in all forms of the public media, serving too for many years as British Association of Dermatologists’ Press Liaison Officer. He was a founder in 1988 of the British Photodermatology Group and then its president, and a founding member of the American Photomedicine Society. He was also until recently President of the European Society for Photodermatology, of which he was again a founder member, and is now an Honorary Life Member. He is a member of the politically influential American Dermatological Association and similar European Dermatology Forum, a former Deputy President and Scientific Committee Chairman of the 2005 London European Academy of Dermatology and Venereology (EADV) Congress, a Past President of the Scientific Committee of the EADV and a regular adviser to UK statutory and government committees, to include recently a National Institute for Health and Care Excellence (NICE) committee on the advantages and disadvantages of sunlight exposure. He was also Congress President of the World Congress on Cancers of the Skin in Edinburgh, Scotland in September 2014, and was recently elected to an Honorary Fellowship of the Australasian College of Dermatologists. Finally, he has many sporting and cultural interests, and speaks excellent French and German.

Professor Angela Hong
Dr Julie Howlie

Dr Julie Howle is a surgical oncologist based at Westmead Hospital, Sydney and is an Associate of the Melanoma Institute Australia. She studied medicine at the University of Sydney, graduating with First Class Honours and completed her training in General Surgery in NSW.  Her two years of post-Fellowship training was in surgical oncology at Westmead and Prince of Wales Hospitals.  In 2010, she completed a Masters in Surgery (University of Sydney), with the management of Merkel cell carcinoma the subject of her dissertation. Her clinical interests include the management of melanoma, Merkel cell carcinoma and other non-melanoma skin cancers, soft tissue sarcoma, thyroid and parathyroid disease.  Dr Howle’s research interests focus primarily on melanoma and Merkel cell carcinoma, and she is currently involved in clinical trials in melanoma and Merkel cell carcinoma, and in translational research at Westmead Hospital.

Dr Ralf Ilchef

More information will be available soon. 

Dr Shivam Kapla

Dr Shivam Kapila is a Dermatologist at the Melanoma Institute Australia and St George Dermatology and Skin Cancer Clinic as well as the 2018 Mohs Surgical Fellow at the Skin Hospital at Darlinghurst and Westmead.

Beyond his Dermatology training, Dr Kapila has significant surgical experience with a Master of Surgery from the University of Sydney and has accredited General Surgical Training experience with the Royal Australasian College of Surgery including completion of the Part I Fellowship Exams and has undertaken Plastic Surgical training at Peter MacCullum Cancer Institute, Melbourne in the Skin Cancer and Melanoma Unit.

He enjoys approaching dermatological disease with both a medical and surgical mindset to bring about the best approach for his patients.

Dr Simon Lee

More information will be available soon 

Dr Karyn Lun

Dr Karyn Lun is a consultant dermatologist working in private practice in South Brisbane, Queensland, and attends Princess Alexandra Hospital and Greenslopes Private Hospital as a Senior Visiting Medical Officer.
She gained her Fellowship of the Australasian College of Dermatologists (ACD), and her training included a year at the prestigious St Johns Institute of Dermatology, St Thomas’ Hospital in London (UK).
In 2004, Dr Lun completed a year of subspecialty training in Mohs micrographic surgery and laser surgery in Sydney. As such, Dr Lun is one of only nine Dermatologists in Queensland and one of nine female Dermatologists in Australia to be on the approved ACD Mohs surgeon list.
She is a Fellow of the American College of Mohs Surgery and a member of several committees of the ACD.
With a strong commitment to patients and the teaching of junior doctors, her interests include skin cancer and Mohs surgery and reconstruction, as well as general dermatology – disorders of the skin, hair and nails.

Dr Victoria Mar

Dr Victoria Mar is a Fellow of the Australasian College of Dermatologists and was appointed Director of the Victorian Melanoma Service in 2018. She is Adjunct Senior Lecturer at the Department of Epidemiology and Preventive Medicine, Monash University. She completed her PhD at Monash University/ VMS and Peter MacCallum entitled ‘Clinical and molecular characteristics of aggressive melanoma’ (2014). She is a board member of the Skin and Cancer Foundation and the Australian and New Zealand Melanoma Trials Group. She has authored and co-authored a number of chapters for the Cancer Council Australia Melanoma Guidelines and is Clinical Lead for the Melanoma Clinical Outcomes Registry.

Dr Alexander Meves

Alexander Meves, MD, is a consultant and associated professor in the Department of Dermatology at Mayo Clinic in Rochester, Minnesota. His clinical interests are related to skin cancer, specifically melanoma. His research which is partially funded by the National Cancer Institute focuses on the biology of skin cancer as it relates to the remodeling of connective tissue and the extracellular matrix.

In addition to his clinical and research activities, Dr. Meves is active in education and mentoring.

Dr. Meves is a diplomate of the American Board of Dermatology and is also a member of the American Academy of Dermatology and the Society for Investigative Dermatology.


Dr Gilberto Moreno

Dr Moreno is a dermatologist and Mohs surgeon at The Skin Hospital Sydney. He graduated from Rosario Medical School in 2003, achieved AHPRA recognition in 2006, completed Basic Physicians training in 2012 and became a Fellow of the Australasian College of Dermatologist in 2016. Other affiliations and interests include being the surgical supervisor for Dermatology registrars at Royal Prince Alfred Hospital (Sydney), expert reviewer for the Australasian Journal of Dermatology, and the Mohs database coordinator for research at The Skin Hospital/Skin and Cancer Foundation Australia. He services the remote and rural population of Dubbo NSW and is actively involved in teaching general practitioners, medical students and dermatology registrars. He supervises a research focus group composed of interns, residents and specialists at The Skin Hospital.


Dr Kate Newland

Dr Kate Newland completed her dermatology training with the Australasian College of Dermatologists in 2013. Following this, she undertook a fellowship at Peter MacCallum Cancer Centre and St Vincent’s hospital in Melbourne, Australia,  gaining experience in cutaneous lymphoma. In conjunction with haematology colleagues, Dr Newland runs multidisciplinary cutaneous lymphoma clinics at the Royal Adelaide Hospital and Flinders Medical Centre in Adelaide, Australia.

Dr Mainthan Palendira

Dr Palendira is a Senior Lecturer in the department of Infectious diseases and Immunology at the University of Sydney and heads a research laboratory at the Centenary institute. His laboratory focusses on human immunology research with a particular interest in cancers and viral infections.
Dr Palendira completed his PhD in the laboratory of Prof Warwick Britton at the Centenary Institute in 2004. He then undertook post-doctoral training in the UK as a CJ Martin fellow. There he worked in the laboratories of both Prof Paul Moss and Prof Alan Rickinson on projects focussed on exploring the characteristics of CMV and EBV-specific CD8+ T cells in humans. On return to Australia he joined Prof Stuart Tangye’s laboratory at the Garvan Institute. In the 7 years he was at the Garvan Institute his work focussed on understanding the molecular pathogenesis of EBV infection in primary immunodeficiencies.


Professor Michael Poulsen

More information will be available soon. 

Professor Miles Prince

Professor Miles Prince is an Australian haematologist and Professor of Medicine at both Melbourne and Monash Universities, Director of the Centre for Blood Cell Therapies at the Peter MacCallum Cancer Centre and Professor/Director of Cancer Immunology and Molecular Oncology at Epworth.   He is a very active clinician, also overseeing clinical and laboratory research – the latter involving stem cell research and cancer immunology. He has been involved in numerous clinical trials of new therapies for blood cancers and has been the Principal Investigator of over 80 clinical trials. Recently, his clinical research focus has been on epigenetic therapies, novel monoclonal antibodies, immunotoxins and immune modulatory agents for the treatment of CTCL.  He has published over 400 peer-reviewed manuscripts. He leads the Cutaneous Lymphoma program in Melbourne and is Chairman of the Australian Skin Lymphoma Network. Miles is a past Board member of the International Society of Cutaneous Lymphoma.

Dr Dong Anh Khuong Quang

Dr Dong-Anh Khuong-Quang is a Herman Fellow from the University of Melbourne, working as a post-doctoral research fellow at the Murdoch Children’s Research Institute in Melbourne (Australia) and as a paediatric oncologist in the Children’s Cancer Centre at the Royal Children’s Hospital Melbourne.

Dr Khuong-Quang obtained her MD with a specialisation in Paediatrics from the University Paris-Descartes 5 in France, and a PhD in Human Genetics from McGill University in Canada. Her research is focused on the genetic characterisation of rare paediatric tumours through the application of next-generation profiling methods with a special interest in brain tumours. She is also involved in several Australian precision medicine projects translating genomic findings into a clinical context.


Professor Darrell S. Rigel, MD MS

DSR headshot 2015 smaller rectangleDarrell S. Rigel, MD MS is a Clinical Professor of Dermatology at New York University Medical Center. He is a graduate of MIT with a BS in Management Information Sciences, an MS (MBA) from the Sloan School of Management at MIT and received his MD from George Washington University. He attended Cornell University Medical Center for Internship in Internal Medicine and completed his training at NYU where he was Resident, Chief Resident, NIH Training Fellow and Dermatology Surgery Fellow. 

Dr. Rigel has delivered over 900 presentations at medical and governmental policy conferences worldwide and has chaired numerous national and international conferences and symposia. He is the author of numerous articles and abstracts in professional journals as well as lead editor of Cancer of the Skin, the major textbook in this field and has testified before Congress and the FDA on related issues. He often appears on National television including CNN, ABC, FOX, NBC and CBS and his research and opinions are regularly cited in the New York Times, Wall Street Journal and many other national magazines and newspapers. 

Dr. Rigel works with many professional and charitable organizations related to his research interests. He
served as President of the American Academy of Dermatology and the American Academy of Dermatology
Association and also served for 9 years as a Director of the American Board of Dermatology. He is also a Past
President of the American Society for Dermatologic Surgery and the American Dermatological Association and is the
current Chair of SkinPAC (the American Academy of Dermatology Association’s political action committee). He is
active in the MIT alumni program serving as a Regional Chair of the MIT Educational Counselor program.

Dr. Rigel has also received numerous awards and honors including the prestigious American Academy of
Dermatology’s Gold Medal – the highest award in the specialty in recognition of a lifetime of achievement, the George
B. Morgan Award from MIT recognizing exceptional achievement by an alumnus and the Humanitarian Award of the
Melanoma Research Foundation. He has also received the American Cancer Society’s National Honor Citation for
Skin Cancer Programs and multiple Presidential Citations from the Academy and American Society for Dermatologic
Surgery for public education programs in skin cancer.

In addition, Dr. Rigel maintains a private practice in Manhattan where he specializes in skin cancer, sun
damage and aging problems of the skin and also lives in Vail, Colorado where he enjoys skiing, golf and fly fishing.

Dr William Ryman

I am a consultant dermatologist at Royal North Shore Hospital, Sydney Skin Hospital, Manly Hospital and Duntroon Royal Military College Health Care Facility Canberra. I am in private practice as Specialist Dermatologist in Bankstown, Sydney. I have special interests in Mohs surgery, radiotherapy, histopathology , contact dermatitis and am currently the Co-Editor in Chief of the Australasian Journal of Dermatology.



A/Professor Robyn Saw

A/Prof Saw is a highly experienced general surgeon, specializing in melanoma patient care and surgical oncology.  She is Head of the Department of Melanoma and Surgical Oncology at Royal Prince Alfred Hospital and is affiliated with Melanoma Institute Australia.  As well as her clinical responsibilities, she is actively involved in melanoma research, focusing on lymphoedema, and quality of care and quality of life in melanoma patients. Translation of research into clinical benefit for patients is the focus of her research activity. She also involved in the education of medical students, surgical trainees, clinicians and patients.

Professor Deborah S. Sarnoff

Board-certified dermatologist Dr. Deborah Sarnoff is the Director of Dermatology at Cosmetique Dermatology, Laser & Plastic Surgery, LLP, New York (with offices on Park Avenue in Manhattan and on Long Island’s Gold Coast), where she specializes in cosmetic dermatology, dermatologic and laser surgery, and Mohs micrographic surgery for the treatment of skin cancer.   Dr. Sarnoff has been a Mohs surgeon for over 30 years and has performed 30,000 cases.

A Clinical Professor of Dermatology at New York University’s School of Medicine, Dr. Sarnoff graduated Summa Cum Laude with a Bachelor of Arts degree from Cornell University, where she was elected to Phi Beta Kappa.   She received her medical degree, with distinction, from the George Washington University Medical School, where she was elected to the Medical Honor Society, Alpha Omega Alpha.  Dr. Sarnoff completed her residency in dermatology and fellowship in Mohs surgery at New York University School of Medicine.  She is a Diplomate of the American Board of Dermatology and a Fellow of the American Academy of Dermatology, American College of Mohs Surgery, The American Society of Dermatologic Surgery and the American Society for Laser Medicine & Surgery.  Dr. Sarnoff is the proud recipient of the Presidential Citation Award from the American Academy of Dermatology and the Humanitarian Award from CancerCare.

Dr Adam Sheridan

Dr Adam Sheridan is a Dermatologist with special expertise in Mohs Micrographic Surgery and Medical Lasers. He is uniquely qualified, having undergone Specialist Dermatology training in Australia and the United Kingdom; and Clinical Research Fellowships in Dermatology and Plastic and Reconstructive Surgery in the UK.

Dr Brindha Shivalingam

More information will be available soon. 

Dr Nicholas Stewart

More information will be available soon. 

Dr Jeffrey Streimer

More information will be available soon. 

Dr Jonathan Stretch


More information will be available soon 


Professor John Thompson

More information will be available soon. 

Dr Edward Upjohn

Dr Edward Upjohn completed his dermatology training at the Royal Melbourne Hospital and also at St. John’s Institute of Dermatology in London. He completed a Mohs micrographic surgery  fellowship in Dallas at the University of Texas – Southwestern Medical Center. He has published numerous articles in peer reviewed journals and has also authored a number of book chapters relating to dermatologic surgery and general dermatology. He is a visiting dermatologist at the Royal Melbourne Hospital and is a Mohs surgeon at the Skin and Cancer Foundation (Melbourne) and The Avenue Hospital.



Professor Michael Veness

Michael Veness is a Senior Staff Specialist in Radiation Oncology working at Westmead hospital, Sydney, and manages skin cancer patients within the context of a long standing multidisciplinary team. He has published extensively on the role of radiotherapy in the setting of high-risk cutaneous SCC and Merkel cell carcinoma. Michael works closely with referring clinicians and is a strong advocate of educating clinicians on the important role of radiotherapy in patients with skin cancer. He authors/co-authors numerous book chapters including the chapter on radiotherapy in Bolognia’s Dermatology text book and has an appointment as a clinical Professor with the University of Sydney.

Doctor Jillian Wells

Dr Jillian Wells is a part time Staff Specialist in the Department of Dermatology at Westmead Hospital. Jillian graduated from the University of Sydney Medical School and completed her Basic Physicians Training before training in Dermatology. She has worked as a consultant in England and Melbourne before returning to Sydney. Jillian’s special interest is cutaneous lymphoma and has headed a multidisciplinary service for this rare condition at Westmead since 2008.

Professor Rainer Hofmann-Wellenhof

Professor Dr. Rainer Hofmann-Wellenhof, director of the Pigmented Skin Lesion Clinic unit and the research unit Teledermatology, Prevention and Innovative Diagnostic Techniques in Dermato-Oncology at the Department of Dermatology, Medical University of Graz, Austria graduated 1987 at the Karl Franzens University of Graz, Austria and obtained the diploma in the specialization in Dermatology and Venereology in 1995. His main research fields are dermato-oncology, dermoscopy, teledermatology and in vivo confocal laser microscopy. He is author and editor of several scientific books and published more than 200 scientific articles in international peer-reviewed journals. His scientific work was awarded several times. He is founding member and treasurer of the International Dermoscopic Society.

Dr Carrie Van Der Weyden

Dr Carrie van der Weyden is a consultant Haematologist and early career clinician researcher based at the Peter MacCallum Cancer Centre in Melbourne. She has an interest in T-cell lymphoma and cutaneous lymphomas, and is a consulting clinician in the PMCC Skin Lymphoma team, seeing referrals from Australia and overseas in a multidisciplinary clinic. She is currently undertaking a higher degree with a focus on novel non-cytotoxic therapies and therapeutic combinations for T-cell lymphoma.

Dr Karen Cheung

Dr Karen Cheung graduated in medicine from the University of Sydney and completed her pathology training at the Concord Repatriation General Hospital. Since then, she has been working in both private and public pathology practices and was an Associate Lecturer at the University of Sydney. She joined the dermatopathology unit at The Skin & Cancer Foundation, Australia in 2003. Dr Cheung enjoys all aspects of dermatopathology and has a strong commitment to teaching, particularly in microscopic teaching sessions. She is also a part-time Staff Specialist at Nepean Hospital, a teaching hospital of the University of Sydney, and has held this position since 1996. She has been tutoring medical students, plastic surgery, dermatology and pathology trainees throughout her career. Her special interests in dermatopathology include inflammatory dermatoses, cutaneous epidermal and appendageal tumours, lymphoma and melanocytic lesions.

Dr Alice Killen

Dr Alice Killen has been CEO of several private health care organisations for the past 23 years. She initially trained as a clinician and then specialised in health policy & management, whilst at Harvard School of Public Health.
She is currently CEO at The Skin Hospital (formerly called Skin & Cancer Foundation Australia), a not-for-profit organisation, founded by Dermatologists in Sydney over 40 years ago, that delivers highly specialised treatment, education & research for diseases of the skin, including skin cancers. The Skin Hospital has two fully accredited & licensed Day Surgery Hospitals & specialist Clinics in Sydney.
Previously, for 5 years Alice was CEO of Castlereagh Imaging and Illawarra Radiology Group, which are wholly owned subsidiaries of Sonic Healthcare Ltd. For 7 years, Alice was CEO at the Mater Hospital North Sydney. Prior to working at the Mater, Alice worked in Boston as a consultant to a firm of Health Economists and in the Department of Health Policy and Management at Harvard
School of Public Health.


Dr Alvin Chong

Assoc. Prof. Alvin Chong MBBS, M.Med, FACD, is Head of Transplant Dermatology Clinic and Director of Education at Skin and Cancer Foundation Victoria. He is also Visiting Specialist and Director of Dermatology Education at St Vincent’s Hospital Melbourne. He is Associate Professor at the University of Melbourne and Principal Dermatologist in Ivanhoe Dermatology Clinic.

Dr Chong has a particular interest in cutaneous carcinogenesis, particularly in solid organ transplant recipients.  He founded the dedicated Transplant Dermatology Clinic at Skin and Cancer Foundation, was Associate Editor of “Textbook of Skin Disease in Organ Transplantation” and has published and presented on this topic, both nationally and internationally.

Andrew Colebatch

More information will be available soon.

Angela Hua

More information will be available soon.

Arthur Martin

More information will be available soon.

Catherine Olsen

Senior Research Officer, Cancer Control Group, QIMR Berghofer Medical Research Institute

Dr Catherine Olsen is a cancer epidemiologist from the Cancer Control Group of the QIMR Berghofer Medical Research Institute in Brisbane. She has research interests in the causes and prevention of cancer particularly skin cancer. Current research activities encompass modifiable lifestyle risk factors and environmental exposures in disease aetiology as well as risk prediction for melanoma and keratinocyte cancer. She currently co-leads a large prospective cohort of over 43,000 Queensland residents established in 2011 with the aim of defining the role of environmental and host/genetic factors in the development of melanoma and other cancers of the skin.

Doctor Chandra Adhikari

Dr Chandra Adhikari is a recently qualified anatomical pathologist. She is the recipient of the 2018 Jani Haenke Melanoma Pathology Fellowship at Melanoma Institute Australia. She undertook medical school training at the University of Kathmandu and has undergone postgraduate training in anatomical pathology at Westmead Hospital and Royal Prince Alfred Hospitals in Sydney. Chandra has a keen interest in dermatopathology.

Dion Forster

Dion Forstner is a radiation oncologist with GenesisCare based at St Vincent’s Hospital Sydney and Macquarie University Hospital. He is currently Dean of Faculty of Radiation Oncology of Royal Australian and New Zealand College of Radiologists (RANZCR), the peak professional body for radiation oncologists in Australia and New Zealand. He is a conjoint Associate Professor at Western Sydney University. He has a longstanding interest in the management of early and advanced skin cancers, and head and neck cancers. He developed the multidisciplinary skin cancer service in south western Sydney and he was instrumental in the significant expansion of the head and neck cancer service. He is committed to multi–disciplinary management of all aspects of care of complex skin malignancies. He has other interests including adoption of  new technologies and techniques, and improving the access of patients to quality radiation therapy. He is a director of Beyond Five which has developed the most comprehensive head and neck cancer and advanced skin cancer patient information resources available anywhere in the world.


Dr Alexander Menzies

Dr Alex Menzies is a Medical Oncologist and Senior Research Fellow at Melanoma Institute Australia, Royal North Shore Hospital and The University of Sydney in Sydney, Australia. He completed specialist oncology training in 2011 and received his PhD from The University of Sydney in 2015 for research exploring the biology of BRAF-mutant melanoma and biomarkers of response and resistance to targeted therapy.  Since 2009 he has been an investigator on over 50 Phase I to III clinical trials of targeted therapies and immunotherapies in melanoma, including the Phase I trials of dabrafenib, combination dabrafenib and trametinib, pembrolizumab and combination ipilimumab and pembrolizumab. He has published several original research and review articles in melanoma, and is a regular invited speaker at national and international meetings. His main research interests are the biology of melanoma and biomarkers of response and resistance to systemic therapy.

Dr Helen Proskurin

More information will be available soon.

Dr Linda Spelman

More information will be available soon.

Elizabeth King

Liz King is the Manager of the Skin Cancer Prevention Unit at Cancer Council NSW and works to change social environments and individual behaviours that promote good sun protection and reduce the risk of skin cancer through strategic program, policy and advocacy initiatives.

With a background in psychology, Liz has worked across a variety of public health and cancer prevention and service delivery areas, including national and state based breast and bowel cancer screening programs, strategic research and program implementation guiding national lung cancer service delivery, overweight and obesity initiatives, and diabetes prevention. Liz has a breadth of stakeholder relationship and engagement experience, and is passionate about translating best practice research into real world outcomes.

Dr Helena Collgros

Dr Helena Collgros (MD) obtained a bachelor in Medicine from the Faculty of Medicine of the Autonomous University of Barcelona (2003-2009). She completed her Dermatology and Venereology specialization in Barcelona in 2014. Afterwards she worked as a dermatologist in the public university hospital Germans Trias i Pujol in Barcelona (2014-2016). Her fields of expertise and research interests include pigmented lesions, melanoma, skin cancer and imaging techniques. She has authored and co-authored more than 20 publications in National and International Journals. Since December 2016 is has been working at the Sydney Melanoma Diagnostic Centre at the Royal Prince Alfred Hospital in Sydney, covering an Area of Need Position attending patients at high risk for developing melanoma and skin cancer, including performing reflectance confocal microscopy.


Jane Hill

More information will be available soon.

Kerry Crotty

Dr Kerry Crotty (BSc (Med), MB BS, FRCPA, FACD) is both a pathologist and dermatologist. Her pathology appointments have included Senior Lecturer in the University of Sydney Pathology Department, Anatomical Pathologist at Royal Prince Alfred Hospital, Dermatopathologist at the Skin and Cancer Foundation, Sydney, and Pathology Research Fellow in the Dermatopathology Department, Massachusetts General Hospital, Harvard Medical School. She established and led a skin pathology practice,CPCPath, for several years and is now at Kossard Dermatopathologists.

She has practised clinical dermatology at the Sydney Melanoma Unit, the Sydney Melanoma Diagnostic Centre and in rural NSW.

Kerry has been President of the Australasian Dermatopathology Society and is the current Secretary. She has convened four of their Annual Scientific Meetings.

She has published widely on skin pathology and the diagnosis of melanoma and other skin cancers. She is a co-author of “Dermoscopy: An Atlas” (Menzies, Crotty, Ingvar, McCarthy). She has been an invited speaker at numerous Australian and international meetings.

Michael Izard

Clinical A/Prof Michael Izard ADM trained in London, and completed his Radiation Oncology training at Westmead, Sydney and was a Clinical fellow at Princess Margaret Hospital, Toronto.  He has his major affiliation for teaching with Sydney University, but also holds a Senior Lecturer role with Macquarie University.  He has been in private practice since 1994, and has been with GenesisCancerCare since its inception, currently working out of The Mater Hospital, St Vincent’s Hospital and Macquarie University Hospital in Sydney. He has strong interests in skin, breast and prostate cancer, as well as brachytherapy and SRS (including the Gamma Knife at Macquarie University Hospital). He is interested in all uses of radiotherapy including benign conditions.  He was a founder member of the Prostate Cancer Foundation of Australia (PCFA), had Ministerial appointment with the NSW EPA and has current Ministerial appointment with the DVA in their SMRC.

Peter Ferguson

Peter attained his medical degree at Otago University and his doctorate at Victoria University of Wellington. Following his registrar training, Peter moved to Sydney to take up the Deborah and John McMurtrie Fellowship in melanoma pathology at the Melanoma Institute of Australia. In 2018, Peter became a staff specialist at the Royal Prince Alfred Hospital where he continues his melanoma research with local and international collaborators.


Professor Christoph Hoeller

More information will be available soon.

A/Professor Pascale Guitera

Pascale Guitera is director of the Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital and the Dermatology Department of the Melanoma Institute Australia. She is holding an Associate Professor academic position at Sydney University with a particular interest in new diagnosis tools.

Professor Sandro Porceddu

More information will be available soon.

Dr Robert Rawson

Dr Robert Rawson is a medical graduate of the Australian National University and commenced his training in Pathology in 2011. He was based primarily at Prince of Wales Hospital in Sydney with rotations to Royal Prince Alfred Hospital and St George Hospital before completing his Fellowship with the Royal College of Pathologists of Australasia in 2016. He was appointed the Cameron Pathology Fellow at the Melanoma Institute of Australia and Royal Prince Alfred Hospital for 2016. His interests include dermatopathology, particularly melanocytic pathology, and gynaecological pathology. He is a member of the translational research group of the Melanoma Institute Australia based at Sydney University through which he is involved in numerous research collaborations.

Professor Steven Kossard

Professor Kossard graduated in Medicine from Sydney University and gained his PhD in 1972 in Melanoma research. He completed his training in clinical dermatology and dermatopathology at St Vincent’s Hospital, Sydney and the Mayo Clinic in the United States.

In 1980, he established the Dermatopathology Unit at the Skin and Cancer Foundation Australia and served for 35 years, up until the sale of the Unit.  During this period Professor Kossard was responsible for training generations of dermatology registrars to integrate dermatopathology within a clinical perspective. Professor Kossard has published extensively in scientific peer reviewed journals. He defined a nevoid form of melanoma in the elderly, a follicular pathway to skin cancer, subtypes of lymphocytic vasculitis and frontal fibrosing alopecia in older women.

In 2016 Professor Kossard was honoured to be appointed to head a dedicated dermatopathology laboratory named in his honour  Professor Kossard continues to apply his dual skills to mentor and train specialist Dermatopathologists as well as dermatology registrars


Professor Pablo Fernández-Peñas

Prof Pablo Fernández-Peñas, MD, PhD, FACD

Pablo Fernández-Peñas is Professor in Dermatology at the University of Sydney, Head of the Department of Dermatology at Westmead Hospital and Head of Research at the Skin and Cancer Foundation Australia in Sydney, Australia. Previously, he was Staff Specialist (Dermatology) at Hospital Universitario de la Princesa and Clinical Professor at the Universidad Autonoma in Madrid, Spain.

Since moving to Sydney in 2007, Pablo has expanded dermatological services, and research and education opportunities in Western Sydney. He opened the Dermatology Comprehensive Clinical Centre at Westmead Hospital with clinics for Severe Psoriasis, Severe Eczema, Hidradenitis Suppurativa, Cutaneous Lymphoma, Graft versus Host Disease, Oncodermatology and High-Risk Melanoma. He set up the Dermatology Clinical Trials and Research Unit, participating in 40+ clinical trials for melanoma, non-melanoma skin cancer, cutaneous lymphoma, hidradenitis and psoriasis. His main fields of interest are oncodermatology, immunology, quality of life, and information technologies, and has 160+ publications in peer review journals. He is a passionate teacher and researcher.


Andrew Spillane

Andrew Spillane MD FRACS B Med Sci BMBS GAID is Professor of Surgical Oncology at The University of Sydney, Northern Clinical School. Profile: Andrew Spillane is Professor of Surgical Oncology at The University of Sydney, Northern Clinical School. He specialises in the surgical management of melanoma and breast cancer. Andrew is a senior VMO surgeon at the Mater North Sydney, Royal North Shore Hospital and North Shore Private Hospitals. Andrew is a Faculty Member of Melanoma Institute Australia (MIA) and chair of the Clinical Committee at MIA and a member of the Executive of the Australian and New Zealand Melanoma Trials Group (ANZMTG). He is immediate past President of Breast Surgeons of Australia and New Zealand Inc. (BreastSurgANZ), a member of the Breast Cancer Trials (formerly ANZBCTG) Scientific Advisory Committee and BCT Breast Surgery Craft Group Lead, as well as Breast sub-editor for the ANZ Journal of Surgery, skin oncology editorial board member of Annals of Surgical Oncology and the Journal of Surgical Oncology and founding co-director of the University of Sydney’s Graduate Certificate in Breast Surgery.

Professor Aleksander Sekulic

Aleksandar Sekulic, M.D., Ph.D., is vice chair of the Department of Dermatology at Mayo Clinic in Arizona and deputy director for Mayo Clinic Cancer Center in Arizona. He also serves as associate director for the Center for Individualized Medicine and chair of the Cutaneous Oncology Disease Group.
Dr. Sekulic’s clinical practice focuses on skin cancers, including malignant melanoma and other pigmented lesions, nonmelanoma skin cancers and cutaneous T-cell lymphoma. His research is centered on identifying the genetics and molecular mechanisms driving skin cancers, as well as finding more effective approaches to diagnose and treat skin cancers. His contribution to development of new therapies is illustrated by his leadership role in bringing the first therapy for treatment of advanced basal cell carcinoma to the FDA for approval.
The research led by Dr. Sekulic has been funded by many prestigious organizations, including the National Cancer Institute, and Stand Up To Cancer Foundation.

Dr Howard Liu

Dr Howard Liu is a Radiation Oncologist at the Princess Alexandra Hospital in Brisbane. He has a specialised interest in head and neck oncology, stereotactic body radiation therapy, skin cancer and sarcoma management. 

Dr Esther Myint


Dr Esther Myint graduated from Institute of Medicine (I), RGN , Burma in 1979 and her received her qualifications in general pathology in 1985 from the same institute. She won a scholarship from the WHO for MSc in Immunology from the University of Birmingham, UK in 1992. Dr Myint was retrained in anatomical pathology in John Hunter Hospital in Newcastle and the Royal Prince Alfred Hospital in Sydney and received her FRCPA Fellowship in 2011. She further received her Dip ICDP-UEMS from Germany, a diploma in dermatopathology in 2016.

Dr Myint has much undergraduate and postgraduate teaching experience and is currently an Adjunct Lecturer at The University of Western Sydney and The University of Notre Dame. Dr Myint is a member of the overseas trained specialist assessment committee of the The Royal College of Pathology, Australasia and commits herself to the education programmes of pathology by the RCPA. She is currently associate examiner for the Anatomical Pathology division of the RCPA.

Her special interests are in lymphoma, skin, brain, gastroenterology, cytopathology and genitourinary pathology. She joined Douglass Hanly Moir Pathology in May 2014.

Professor Joseph Alcalay

Professor JOSEPH ALCALAY, MD. Born 1955, Tel-Aviv, Israel. Medical studies at Tel-Aviv University, Sackler School of medicine. MD degree with Magna cum laude. Dermatology residency in Beilinson medical center.  Three years fellowship in Mohs surgery and Immunology, Department of Dermatology, Baylor college of Medicine and Department of Immunology, MD Anderson cancer Center, Houston , Texas, USA.

Private practice and director of Mohs surgery unit, Assuta medical center, Tel-Aviv. Founder and Past president of the Israel society of dermatologic surgery, past president of the Israel Society of Dermatology and Venereology. Past president of the International society of dermatologic surgery. Congress president of the World Congress of Cancers of the skin, Tel Aviv 2009. Past secretary of the European society for micrographic surgery. Member of the American academy of dermatology and the European Academy of Dermatology and Venereology. Program director of the American college of Mohs surgery. International advisory board of the skin cancer foundation. Author of the chapter “Mohs micrographic surgery” in Fitzpatrick’s textbook of dermatology in general medicine, 2013. Reviewer for dermatologic surgery and archives of dermatology. Author of 100 publications.

Dr Oana Crainic

Dr. Oana Crainic graduated from medicine at the University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania. After spending eight years in clinical medicine, including dermatology, in both Romania and New Zealand, she completed her postgraduate training in anatomical pathology in Christchurch, New Zealand, and the Melanoma Institute of Australia. Dr. Crainic developed a special interest in dermatopathology with an emphasis on melanocytic pathology. She works at Douglass Hanly Moir Pathology since May 2015. In 2016, she received International Board Certification in Dermatopathology under the auspices of the International Committee for Dermatopathology (ICDP/UEMS). Dr. Crainic has a broad range of interests in surgical pathology, with special interests in dermatopathology, haematolymphoid pathology and gynaecological pathology, as well as cytopathology. She has expertise in biopsies for alopecia and direct immunofluorescence. She is also involved in a variety of teaching activities for medical students, pathology and dermatology registrars.

Dr Anna Nichols

Anna J. Nichols, MD, PhD is Assistant Professor in the Department of Dermmatology and Cutaneous Surgery at the University of Miami Miller School of Medicine. Dr. Nichols’ main clinical and research interests are focused on preventing nonmelanoma skin cancer and developing novel, cost-effective ways to treat tumors non-invasively. She spearheads a High-Risk Skin Cancer Clinic dedicated to serving patients at risk for multiple or aggressive nonmelanoma skin cancers, such as solid organ transplant recipients. She was recently awarded the 2018 Skin Cancer Foundation Research Grant to test the novel hypothesis that intratumoral delivery of the 9-valent human papillomavirus vaccine is an effective treatment strategy for cutaneous squamous cell carcinoma. Additionally, Dr. Nichols is the Co-Director of our department’s Clinical and Translational Research Unit where she oversees a team of research coordinators and fellows who support the department’s numerous research projects. She is currently involved in projects on skin cancer chemoprevention and treatment, inpatient and emergency department dermatology consults, psoriasis, hidradenitis suppurativa and androgenetic alopecia. She is a member of the University of Miami’s Institutional Review Board.

Dr Saleem Loghdey

Dr Saleem Loghdey is a dermatologist who moved to Australia from the UK in 2013.  He grew up in South Africa where he did his undergraduate medical training at the University of Cape Town qualifying in 1995.  After doing his internship in 1996 he worked as a Senior House Officer / Medical Officer in General medicine/ Rheumatology for 2 years at Groote Schuur Hospital in Cape Town. The exposure to connective tissue diseases stimulated his interest in dermatology. 

He subsequently started his training in dermatology at the University of Stellenbosch, Cape Town in 1999, becoming a Fellow of the College of Dermatologists of South Africa in 2003.  After a short stint in private practice in Cape Town he worked in Pediatric Dermatology at Red Cross Children’s Hospital in Cape Town for 6 months. 

Saleem relocated to the UK in 2004 gaining his CCST (UK) in dermatology and worked as a Consultant Dermatologist in the NHS until the end of 2010.  He was then selected to do a 12 month Mohs Micrographic Surgery / Dermatological Surgery/laser Fellowship at the prestigious Oxford Dermatology Skin Surgery Unit in 2011.

In 2012 Saleem was again selected for a further 12 month Fellowship in advanced Mohs Surgery / Dermatological Surgery / Laser Surgery at Nottingham Dermatology unit in the UK. During his training in Nottingham he gained extensive experience in treating Dermatofibrosarcoma protuberans and has published on this subject.

He completed his requirements for Fellowship of the Australasian College of Dermatologists in 2014.He currently works in Private practice- Miranda,NSW  and is a Visiting Medical Officer at Kareena Private Hospital and Westmead Skin Hospital.

His dermatology special interests include skin cancer, pediatric dermatology, Laser surgery connective tissue diseases and dermatopathology.

Cameron Sugden

Cameron Sugden is the Social Marketing and Campaign Coordinator for skin cancer prevention at the Cancer Institute NSW. Cameron manages the Pretty Shady and Your Time in the Sun campaigns to improve sun protection behaviours among young people in NSW ( He also chairs the Public Education Working Group of the NSW Skin Cancer Prevention Advisory Committee.

Cameron has a multidisciplinary background in social marketing, psychology and public health and has previously managed health promotion initiatives for the Australian Government and World Health Organization in the South Pacific.


Registrations are Open!


WCCS 2018 Congress